Women & Infants Hospital is both an elite tertiary care hospital and Rhode Island’s safety net hospital for women and newborns. Our faculty members care for each patient with intense attention and focus, no matter her background or circumstances.
Brown's department consists of both hospital-based full-time faculty, organized by divisions, and community-based faculty physicians in the community. We are also proud of our residency program and the residents. Interested resident applicants will find pertinent information about the program and the application process on our website. 
Physicians at Women & Infants Hospital deliver the vast majority of babies born each year in the region, making the hospital the eleventh largest stand-alone obstetrical service in the United States. In addition to both low risk and high risk obstetrics, we provide a complete range of gynecologic services.
The Division of Gynecologic Oncology and its Breast Health Center, also known as the Program in Women's Oncology, has created a unique environment which provides highly effective and compassionate care for cancer patients and their families. The Program is built around a steadfast philosophy and core values that focus on a multidisciplinary, prospective, and patient-centered care team. A hallmark of the program is the prospective tumor board process. Following the initial visit, cases go before a multidisciplinary panel that provides expert opinions on the most effective course of treatment when planning makes the most difference in the life of the patient – before treatment begins.
The Division of Maternal-Fetal Medicine is a unique team who serve both as consultants and primary obstetric providers for women with a wide range of chronic medical conditions, obstetric complications, and fetal abnormalities. The maternal-fetal medicine specialists not only provide the full range of prenatal diagnosis and pregnancy monitoring services, but they are also dedicated to taking care of vulnerable, high-risk women in the hospital. The division's goal is:
In collaboration with the Division of Obstetric and Consultative Medicine at Women & Infants and the Alpert Medical School, the Division introduced New England’s only fully Integrated Program for High-Risk Pregnancy. Maternal-Fetal Medicine is also an integral part of the multi-disciplinary perinatology team at Women & Infants and the Fetal Treatment Program, a joint venture of Women & Infants, Hasbro Children's Hospital, and Brown University.
The mission of the Division of Reproductive Endocrinology and Infertility (REI) is to provide the necessary services, coordinate care and walk the journey with patients in building their family, one step at a time. The staff is dedicated to the needs of patients first, while enhancing technological innovations and teaching the future leaders in the field, providing comprehensive care to couples experiencing fertility difficulties, those seeking to preserve their fertility, those seeking to preserve their fertility, those experiencing recurrent pregnancy losses, those who are carriers or affected with genetic disorders, and those suffering from reproductive hormonal dysfunction across the spectrum of their reproductive timeline. The division also plays a pivotal role in medical student, resident and fellow education. Several new educational initiatives were recently launched by faculty that led to the development of a residency curriculum in gynecological ultrasound, as well as pediatric and adolescent gynecology.
The Division of Urogynecology and Reconstructive Pelvic Surgery at Women & Infants is a tertiary care center whose faculty is all subspecialty fellowship trained board-certified/board-eligible in Female Pelvic Medicine and Reconstructive Surgery (FPMRS). It is the only group of fellowship trained and FPMRS-certified urogynecologists in Rhode Island. The division's clinical expertise is in the diagnosis and treatment of pelvic floor disorders such as:
Its clinical center is one of eight national clinical sites of the NICHD Pelvic Floor Disorders Network (PFDN) and conducts multi-centered trials studying pelvic floor disorders.
The Department of ObGyn has a robust research portfolio and is the member of several grant networks, including MFMU, PFDN, CCTN and NRG. In 2021, the department received $4.4 million in funding.
